Thomas Cerny
A Bayesian generalized age-period-cohort power model for cancer projections
Jürgens V, ess s, Cerny T, Vounatsou P. A Bayesian generalized age-period-cohort power model for cancer projections. Stat Med 2014; 33:4627-36.
03.07.2014A Bayesian generalized age-period-cohort power model for cancer projections
03.07.2014Stat Med 2014; 33:4627-36
Jürgens Verena, ess silvia, Cerny Thomas, Vounatsou Penelope
Diffuse large B-cell lymphoma in elderly patients: a retrospective analysis
Diem S, Ess S, Cerny T, Früh M, Hitz F. Diffuse large B-cell lymphoma in elderly patients: a retrospective analysis. Eur J Intern Med 2014; 25:577-82.
28.05.2014Diffuse large B-cell lymphoma in elderly patients: a retrospective analysis
28.05.2014Eur J Intern Med 2014; 25:577-82
Diem Stefan, Ess S, Cerny Thomas, Früh Martin, Hitz Felicitas
Discrete improvement in racial disparity in survival among patients with stage IV colorectal cancer: a 21-year population-based analysis
Castleberry A, Candinas D, Mantyh C, Cerny T, Warschkow R, Brugger L, Berry M, Tarantino I, Gueller U, Worni M. Discrete improvement in racial disparity in survival among patients with stage IV colorectal cancer: a 21-year population-based analysis. J Gastrointest Surg 2014; 18:1194-1204.
15.04.2014Discrete improvement in racial disparity in survival among patients with stage IV colorectal cancer: a 21-year population-based analysis
15.04.2014J Gastrointest Surg 2014; 18:1194-1204
Castleberry A W, Candinas D, Mantyh C R, Cerny Thomas, Warschkow Rene, Brugger L, Berry M F, Tarantino Ignazio, Gueller Ulrich, Worni M
Neuroborreliosis Mimicking Leptomeningeal Carcinomatosis in a Patient With Breast Cancer: A Case Report
Fischer S, Weber J, Senn-Schönenberger I, Cerny T, Hundsberger T. Neuroborreliosis Mimicking Leptomeningeal Carcinomatosis in a Patient With Breast Cancer: A Case Report. J Investig Med High Impact Case Rep 2014; 2:2324709614529417.
28.03.2014Neuroborreliosis Mimicking Leptomeningeal Carcinomatosis in a Patient With Breast Cancer: A Case Report
28.03.2014J Investig Med High Impact Case Rep 2014; 2:2324709614529417
Fischer Stefanie, Weber Johannes, Senn-Schönenberger Isabelle, Cerny Thomas, Hundsberger Thomas
Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study
Jörger M, Schaer-Thuer C, Koeberle D, Matter-Walstra K, Gibbons-Marsico J, Diem S, Thürlimann B, Cerny T. Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study. Eur J Clin Pharmacol 2014; 70:719-25.
11.03.2014Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study
11.03.2014Eur J Clin Pharmacol 2014; 70:719-25
Jörger Markus, Schaer-Thuer C, Koeberle D, Matter-Walstra K, Gibbons-Marsico J, Diem Stefan, Thürlimann Beat, Cerny Thomas
Outcome of mantle cell lymphoma patients treated at a single institution over the past decade
Hitz F, Diem S, Haile S, ess s, Cerny T, Mey U. Outcome of mantle cell lymphoma patients treated at a single institution over the past decade. Hematol Oncol 2013
11.12.2013Outcome of mantle cell lymphoma patients treated at a single institution over the past decade
11.12.2013Hematol Oncol 2013
Hitz Felicitas, Diem Stefan, Haile Sarah, ess silvia, Cerny Thomas, Mey Ulrich
Spiritual Experiences of Transcendence in Patients With Advanced Cancer
Renz M, Mao S, Omlin A, Büche D, Cerny T, Strasser F. Spiritual Experiences of Transcendence in Patients With Advanced Cancer. Am J Hosp Palliat Care 2013
02.12.2013Spiritual Experiences of Transcendence in Patients With Advanced Cancer
02.12.2013Am J Hosp Palliat Care 2013
Renz Monika, Mao Schuett M, Omlin Aurelius, Büche Daniel, Cerny Thomas, Strasser Florian
Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction
Jörger M, Huitema A, Koeberle D, Rosing H, Beijnen J, Hitz F, Cerny T, Schellens J, Gillessen Sommer S. Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction. Cancer Chemother Pharmacol 2013; 73:113-24.
29.10.2013Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction
29.10.2013Cancer Chemother Pharmacol 2013; 73:113-24
Jörger Markus, Huitema A D R, Koeberle D, Rosing H, Beijnen J H, Hitz Felicitas, Cerny Thomas, Schellens J H M, Gillessen Sommer Silke
Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008
Worni M, Gueller U, White R, Castleberry A, Pietrobon R, Cerny T, Gloor B, Koeberle D. Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008. Pancreas 2013; 42:1157-63.
01.10.2013Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008
01.10.2013Pancreas 2013; 42:1157-63
Worni Mathias, Gueller Ulrich, White Rebekah R, Castleberry Anthony W, Pietrobon Ricardo, Cerny Thomas, Gloor Beat, Koeberle Dieter
Relative Survival is an Adequate Estimate of Cancer-Specific Survival: Baseline Mortality-Adjusted 10-Year Survival of 771 Rectal Cancer Patients
Tarantino I, Achermann P, Gueller U, Ulrich A, Schmied B, Horber D, Cerny T, Stanga Z, Warschkow R. Relative Survival is an Adequate Estimate of Cancer-Specific Survival: Baseline Mortality-Adjusted 10-Year Survival of 771 Rectal Cancer Patients. Ann Surg Oncol 2013; 20:3877-2884.
02.08.2013Relative Survival is an Adequate Estimate of Cancer-Specific Survival: Baseline Mortality-Adjusted 10-Year Survival of 771 Rectal Cancer Patients
02.08.2013Ann Surg Oncol 2013; 20:3877-2884
Tarantino Ignazio, Achermann Philipp, Gueller Ulrich, Ulrich Alexis, Schmied Bruno, Horber Daniel, Cerny Thomas, Stanga Zeno, Warschkow Rene
Predictors of satisfaction with treatment decision, decision-making preferences, and main treatment goals in patients with advanced cancer
Hitz F, Ribi K, Li Q, Klingbiel D, Cerny T, Koeberle D. Predictors of satisfaction with treatment decision, decision-making preferences, and main treatment goals in patients with advanced cancer. Support Care Cancer 2013; 21:3085-93.
05.07.2013Predictors of satisfaction with treatment decision, decision-making preferences, and main treatment goals in patients with advanced cancer
05.07.2013Support Care Cancer 2013; 21:3085-93
Hitz Felicitas, Ribi Karin, Li Qiyu, Klingbiel Dirk, Cerny Thomas, Koeberle Dieter
Management of elderly patients with advanced non-small cell lung cancer: a single-center experience
Früh M, Besrour H, Gillessen Sommer S, Jörger M, Hitz F, Savidan A, Cerny T, Ess S. Management of elderly patients with advanced non-small cell lung cancer: a single-center experience. Chemotherapy 2013; 59:42-50.
02.07.2013Management of elderly patients with advanced non-small cell lung cancer: a single-center experience
02.07.2013Chemotherapy 2013; 59:42-50
Früh Martin, Besrour H, Gillessen Sommer Silke, Jörger Markus, Hitz Felicitas, Savidan A, Cerny Thomas, Ess S
Tobacco-related cancer mortality: projections for different geographical regions in Switzerland
Jürgens V, ess s, Phuleria H, Früh M, Schwenkglenks M, Frick H, Cerny T, Vounatsou P. Tobacco-related cancer mortality: projections for different geographical regions in Switzerland. Swiss Med Wkly 2013; 143:w13771.
25.06.2013Tobacco-related cancer mortality: projections for different geographical regions in Switzerland
25.06.2013Swiss Med Wkly 2013; 143:w13771
Jürgens Verena, ess silvia, Phuleria Harish C, Früh Martin, Schwenkglenks Matthias, Frick Harald, Cerny Thomas, Vounatsou Penelope
Thymoma with molecularly verified "conversion" to T lymphoblastic leukemia/lymphoma over 9 years
Ertel V, Früh M, Guenther A, Cerny T, Fretz C, Cogliatti S. Thymoma with molecularly verified "conversion" to T lymphoblastic leukemia/lymphoma over 9 years. Leuk Lymphoma 2013; 54:2765-8.
21.06.2013Thymoma with molecularly verified "conversion" to T lymphoblastic leukemia/lymphoma over 9 years
21.06.2013Leuk Lymphoma 2013; 54:2765-8
Ertel Vera, Früh Martin, Guenther Alexander, Cerny Thomas, Fretz Christian, Cogliatti Sergio
Cancer survivors in Switzerland: a rapidly growing population to care for
Herrmann C, Cerny T, Savidan A, Vounatsou P, Konzelmann I, Bouchardy C, Frick H, ess s. Cancer survivors in Switzerland: a rapidly growing population to care for. BMC cancer 2013; 13:287.
14.06.2013Cancer survivors in Switzerland: a rapidly growing population to care for
14.06.2013BMC cancer 2013; 13:287
Herrmann Christian, Cerny Thomas, Savidan Anita, Vounatsou Penelope, Konzelmann Isabelle, Bouchardy Christine, Frick Harald, ess silvia
Bayesian spatio-temporal modelling of tobacco-related cancer mortality in Switzerland
Jürgens V, ess s, Phuleria H, Früh M, Schwenkglenks M, Frick H, Cerny T, Vounatsou P. Bayesian spatio-temporal modelling of tobacco-related cancer mortality in Switzerland. Geospat Health 2013; 7:219-36.
01.05.2013Bayesian spatio-temporal modelling of tobacco-related cancer mortality in Switzerland
01.05.2013Geospat Health 2013; 7:219-36
Jürgens Verena, ess silvia, Phuleria Harish C, Früh Martin, Schwenkglenks Matthias, Frick Harald, Cerny Thomas, Vounatsou Penelope
[Cancer screening - principles, evaluation and implementation]
Egger M, Zwahlen M, Cerny T. [Cancer screening - principles, evaluation and implementation]. Ther Umsch 2013; 70:195-203.
01.04.2013[Cancer screening - principles, evaluation and implementation]
01.04.2013Ther Umsch 2013; 70:195-203
Egger Matthias, Zwahlen Marcel, Cerny Thomas
Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients
Tarantino I, Cerny T, Steffen T, Mueller S, Schmied B, Köberle D, Merati-Kashani K, Worni M, Warschkow R, Gueller U. Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients. Br J Cancer 2012; 107:266-74.
26.06.2012Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients
26.06.2012Br J Cancer 2012; 107:266-74
Tarantino Ignazio, Cerny Thomas, Steffen Thomas, Mueller Sascha, Schmied B M, Köberle Dieter, Merati-Kashani K, Worni M, Warschkow Rene, Gueller Ulrich
Palliative Systemtherapie des metastasierten Weichteil-Sarkoms
Cerny T, Rothermundt C, Putora P. Palliative Systemtherapie des metastasierten Weichteil-Sarkoms. info@onkologie 2012; 2012:6-9.
27.04.2012Palliative Systemtherapie des metastasierten Weichteil-Sarkoms
27.04.2012info@onkologie 2012; 2012:6-9
Cerny Thomas, Rothermundt Christian, Putora Paul Martin
Dosing algorithm to target a predefined AUC in patients with primary central nervous system lymphoma receiving high dose methotrexate
Jörger M, Ferreri A, Krähenbühl S, Schellens J, Cerny T, Zucca E, Huitema A. Dosing algorithm to target a predefined AUC in patients with primary central nervous system lymphoma receiving high dose methotrexate. Br J Clin Pharmacol 2012; 73:240-7.
01.02.2012Dosing algorithm to target a predefined AUC in patients with primary central nervous system lymphoma receiving high dose methotrexate
01.02.2012Br J Clin Pharmacol 2012; 73:240-7
Jörger Markus, Ferreri Andrés J M, Krähenbühl Stephan, Schellens Jan H M, Cerny Thomas, Zucca Emanuele, Huitema Alwin D R